Genetics Network Co-Chairs:
Anu Loukola, Ph.D.
Dr. Anu Loukola is a senior scientist and an Adjunct Professor at the Institute for Molecular Medicine Finland (FIMM), at the University of Helsinki, Finland. Dr. Loukola’s research is aimed at identifying novel genes and pathways associated with smoking behavior, nicotine dependence, and co-morbid neuropsychiatric disorders. She is using twin and population samples to identify genetic and epigenetic influences on smoking behavior. Dr. Loukola is a member of the'Finland Smoke-free by 2030' scientific committee. As the SRNT Genetics Network co-chair, she works with Dr. David and other members of the network to develop projects that disseminate information about the role of genetics in smoking behaviors, via Webinars, workshops and symposia at the annual meeting, paper development, and website content.
SRNT Activities: Member since 2012, Genetics Network co-chair since 2015, co-organized several symposia and workshops at annual meetings
Marissa Ehringer, Ph.D.
Dr. Marissa Ehringer is an Associate Professor in the Department of Integrative Physiology and a Faculty Fellow at the Institute for Behavioral Genetics at the University of Colorado, Boulder. Dr. Ehringer's research is aimed at identifying and understanding genetic underpinnings associated with alcohol and nicotine addiction, using a combination of human statistical genetics, molecular genetics, and mouse behavioral genetic models.
SRNT Activities: As co-chair, she works with Dr. Loukola and other members of the network to develop projects that disseminate information about the role of genetics in smoking behaviors, via Webinars, workshops at the annual meeting, paper development, and website content. She is also a member of the Basic Science Network, which allows her to serve as a liaison between these two groups.
Advisory Committee Members:
Andrew Bergen, Ph.D.
Andrew Wells Bergen (PhD ’96 George Washington University), attended Haverford College, the University of California Santa Cruz, the Johns Hopkins University and the George Washington University. He served as pre and post-doctoral fellow in the Laboratory of Neurogenetics, NIAAA, NIH, and as a post-doctoral fellow in the Division of Cancer Epidemiology and Genetics, NCI. His career has spanned work as a Staff Scientist at NCI, a Program Director at SRI International, and applied research settings (Cellmark Diagnostics and Biognosis U.S., Inc). His research has been funded by venture, industry, philanthropy, and the NIH. Dr. Bergen has served the SRNT as a member and Co-chair of the Genetics Network, as a workshop organizer, and as a member of the Genetics Treatment Working Group.
Dr. Bergen’s past contributions to nicotine and tobacco research include as service as Investigator or Member of study consortia or committees in lung cancer (EAGLE), nicotine dependence (EAGLE, COGEND, PNAT, STOMP), nicotine metabolism (DMET), chronic stress and substance dependence (OYSUP), and response to smoking cessation treatments (PNAT, DMET).
Sean P. David, M.D., S.M., D.Phil.
Dr. David is a physician scientist with training in family medicine, public health, health policy, and pharmacogenetics. He is an Associate Professor of Medicine at Stanford University School of Medicine. He was an National Academy of Medicine (NAM) Anniversary Fellow (2011-2013), a participant in the Truth Initiative Strategic Dialogue on Harm Reduction II, member of the NAM Committee on the Evidence Base for Genetic Testing, and serves on the Board of US BMJ Fellows. He is presently a faculty member with the Division of Primary Care and Population Health, the Meta Research Innovation Center at Stanford (METRICS), and Stanford Research into The Impact of Tobacco Advertising (SRITA) at Stanford University. He led the Study of Tobacco Use in Minority Populations (STOMP) Genetics Consortium, is a co-investigator with the GWAS and Sequencing Consortium of Alcohol and Nicotine Use (GSCAN) and leads the Cochrane Review 'Genomic analyses to guide choice of treatment for smoking cessation' with Andrew Bergen and Marcus Munafò.
SRNT Activities: As a member of the SRNT Global Genetics and Treatment networks and through work as Co-Chair of the 2013 and Chair of the 2014 Program Committees for the SRNT Annual Meeting, he is active in multiple efforts to engage and inform the SRNT membership on translation of genomic knowledge to clinical research, precision health, and science-based policy to improve population health.
Jaakko Kaprio, M.D., Ph.D.
Jaakko Kaprio, M.D., Ph.D. is Professor of Genetic Epidemiology, University of Helsinki, Finland since 2001. He currently holds a five-year research professorship funded by the Academy of Finland and is Director of the Institute for Molecular Medicine FIMM as of Oct 1, 2015. Dr. Kaprio has worked in genetic epidemiology, with a focus on risk factors of non-communicable disease, especially smoking and alcohol use and dependence. He has worked with the Finnish Twin Cohort studies since 1976, and with other population-based samples in Finland and has engaged in extensive international collaborations, including NIH and EU funded projects. He has served as President of the Society for Research on Nicotine and Tobacco European chapter, and has been active in tobacco-related NGOs in Finland. He was President of the Behavior Genetics Association 2015-2016. Jaakko Kaprio has 1020 papers listed in PubMed.
SRNT Activities: SRNT-E member, served on board of SRNT-E and as SRNT President, served as co-chair of SRNT genetics network, and served as European member of the SRNT Board
Tellervo Korhonen, Ph.D.
Tellervo Korhonen, Ph.D. is Adjunct Professor of Public Health, at University of Helsinki, Finland since 2009 and University Researcher at University of Eastern Finland since 2012. Dr. Korhonen has worked in public health science and genetic epidemiology with a focus on risk factors of non-communicable diseases, especially smoking and nicotine dependence, as well as essential co-occurring conditions, such as mental disorders and substance abuse. Since 2016 she is working as senior scientist at the Finnish Institute for Molecular Medicine (FIMM). She is responsible for supervision of five PhD students affiliated with FIMM and/or Department of Public Health at the University of Helsinki and of two students affiliated with the University of Eastern Finland. As of March 2017 she has total of 108 publications, with 94 of them being peer-reviewed publications.
SRNT Activities: SRNT member since 2002, serving as Member Delegate for Europe in the Board of Directors until 2013, Board Liaison for the SRNT Genetics Network
Nancy Saccone, Ph.D.
5/15/2017 » 5/18/2017
Rocky Mountain Tobacco Treatment Specialist Certification (RMTTS-C)